<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Endocrinology</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/88B7F00C-5E0C-4B24-B047-A10537C9B2E2"><gtr:id>88B7F00C-5E0C-4B24-B047-A10537C9B2E2</gtr:id><gtr:firstName>Moffat</gtr:firstName><gtr:surname>Nyirenda</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501934"><gtr:id>990856C5-D613-4E92-A44D-49BC4C60E58D</gtr:id><gtr:title>Glucocorticoids and foetal programming of adult hyperglycaemia: dissecting the fundamental molecular mechanisms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501934</gtr:grantReference><gtr:abstractText>Low birth weight is associated with increased risk of diabetes in adulthood. Exposure of the foetus in the womb to excess ?stress? steroid hormones called glucocorticoids has been suggested as a potential cause. In animals and humans prenatal glucocorticoid treatment reduces birth weight and permanently elevates blood glucose (hyperglycaemia) and blood pressure. These effects are passed onto future generations without further glucocorticoid treatment. Stressful events/illnesses during pregnancy increase glucocorticoid levels, and may have similar long-term effects. We have shown in rat liver that these effects might be mediated by changes in expression of two genes called GR and HNF4a. We now wish to prove this notion. Additionally, because these genes are also present in the pancreas where they control insulin secretion, we will determine whether their expression is also deranged in this organ and whether this causes disturbed insulin secretion. We also wish to elucidate the mechanisms through which the changes in these genes are inherited across generations. These studies may provide new insights into causes of diabetes, and its link with low birth weight. They may also indicate ways of preventing or ameliorating diabetes, as well as inform the therapeutic use of glucocorticoids in pregnant mothers and young babies.</gtr:abstractText><gtr:technicalSummary>Numerous epidemiological studies have shown that low birth weight is associated with increased prevalence of cardiometabolic disorders, including type 2 diabetes. Recent studies have shown that prenatal exposure to glucocorticoid ?stress? hormones might underpin this association; treating pregnant rats with the glucocorticoid dexamethasone reduces birth weight, and causes lifelong hypertension and hyperglycaemia in the adult offspring. Intriguingly, these phenotypes are transmitted into subsequent generations without further dexamethasone treatment, suggesting glucocorticoids may induce epigenetic changes. Our recent studies on the liver show that prenatal dexamethasone associates with early-onset and lifelong overexpression of two key transcription factors that regulate metabolism, namely the glucocorticoid receptor GR and hepatocyte nuclear factor 4 alpha (HNF4a). This may be of functional significance since hepatic expression of PEPCK, the rate-limiting step of gluconeogenesis and an important target of both GR and HNF4a, is also permanently increased. Hepatic GR and PEPCK expression is increased in other animal models of foetal programming of hyperglycaemia (maternal protein restriction or uterine artery ligation), suggesting that GR and/or HNF4a may mediate effects of various early environmental insults on subsequent hyperglycaemia.

GR and HNF4a are also particularly important for development and function of the endocrine pancreas - where glucocorticoids inhibit insulin secretion from &amp;szlig;-cells and mutations of the HNF4a gene cause maturity-onset diabetes of the young1 (MODY1). Deranged expression of these genes in the pancreas would therefore have significant pathophysiological consequences and may contribute to hyperglycaemia in this model.

The main aim of the proposed research is to elucidate the fundamental molecular mechanisms through which prenatal glucocorticoid exposure causes permanent hyperglycaemia. Specifically we will: 1) use a transgenic ach to test whether hepatic HNF4a over-expression is sufficient to induce PEPCK expression and hyperglycaemia; 2) examine whether prenatal dexamethasone alters GR and HNF4a expression in pancreatic beta-cells and determine whether changes affect long term beta-cell function (insulin secretion); 3) determine the methylation status of the GR and HNF4a promoters in order to elucidate the mechanisms through which dexamethasone increases expression of these genes and how this is transmitted across generations.

These studies may provide new insights into the pathogenesis of type 2 diabetes and its relationship with birth weight, as well as indicate targets for prevention and/or therapy. If the epigenetic changes could easily be determined with a blood sample, it would allow early testing (before disease manifestation) in children with low birth weight or those treated with glucocorticoids perinatally to accelerate lung maturity in cases of premature labour.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>751570</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Festival stand</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>19B2736E-E09E-402E-8D09-81FDA782CDFE</gtr:id><gtr:impact>session well attended by a number of people (different age groups)
We undertook a number of community activities to understand the cultural significance of salt, knowledge on its association with disease (blood pressure), and how a salt reduction intervention might be accepted. These activities (individual interviews and focus group discussions) have included people across different age groups, key informants and patient groups, both in urban and rural areas. The findings of these discussions were then fed back to the community and policy makers

Partcular interest from the public was on trangenerational effects of foetal programming</gtr:impact><gtr:outcomeId>Szp2C8E7Yi1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2010,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>General Practioners' meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DFED7BDE-99C6-4042-B562-8BCCA1F0C68A</gtr:id><gtr:impact>I gave a talk on my research at meeting arranged by Primed for GPs across Scotland

This was the first time that a significant number of the GPs heard of/appreciated the impact of fetal programming of diabetes. The talk was very well received.</gtr:impact><gtr:outcomeId>73DCBC190AA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Partnership Scheme</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>15D0CD8D-0F58-40BB-BA08-428966D68D03</gtr:id><gtr:outcomeId>NyqBGuR9Zne</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B3414AA-7711-439D-89C8-75819B0BE4FE</gtr:id><gtr:title>Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>317835BAE3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADC8D835-2976-4077-8360-CD1EABF460C2</gtr:id><gtr:title>Prenatal programming of hepatocyte nuclear factor 4alpha in the rat: A key mechanism in the 'foetal origins of hyperglycaemia'?</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>F541A58B2F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BBB67A8-0F6B-43EA-A2D2-6C673B558374</gtr:id><gtr:title>Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Current diabetes reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba1cbe73aa6a5352592f8587a1a6fc85"><gtr:id>ba1cbe73aa6a5352592f8587a1a6fc85</gtr:id><gtr:otherNames>Lockman KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1573-3998</gtr:issn><gtr:outcomeId>ofjAdHyE7kM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7092E564-74A2-421E-B955-6A70CB917FCE</gtr:id><gtr:title>Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6a07e95c767d5396f3151e0611dfd0"><gtr:id>2c6a07e95c767d5396f3151e0611dfd0</gtr:id><gtr:otherNames>Drake AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>7AB649F5C4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD4976C-46B0-49C7-9A2F-AC59C73E99A3</gtr:id><gtr:title>Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>9DFF979319E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F1D970-26F9-428B-B0B8-B83C9F0789B0</gtr:id><gtr:title>Prenatal glucocorticoid overexposure causes permanent increases in renal erythropoietin expression and red blood cell mass in the rat offspring.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b7ac8305311090340cdd18aed8fba0"><gtr:id>76b7ac8305311090340cdd18aed8fba0</gtr:id><gtr:otherNames>Tang JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>Emeyfr5r2vK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B67DBDD4-6C2D-437F-AC18-B7C7B5E56932</gtr:id><gtr:title>Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves disease treated with carbimazole.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>F75D4FDEC50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9C4A7E7-15CC-4426-8341-8099D139810F</gtr:id><gtr:title>A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c525d7ba1b7e683e731805c6b72b7b"><gtr:id>32c525d7ba1b7e683e731805c6b72b7b</gtr:id><gtr:otherNames>Raubenheimer PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>B323269902E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96AFD88D-ABB0-4DB2-8559-DEEB88FE2534</gtr:id><gtr:title>Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/755bdde6415bf0bc5b52b495bf44f964"><gtr:id>755bdde6415bf0bc5b52b495bf44f964</gtr:id><gtr:otherNames>Macfarlane DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>dksnUivEWXq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E286C54-9676-4B16-B88C-746AF5EE0D37</gtr:id><gtr:title>Hyperkalaemia.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>487BCE9E7FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE218D4B-4BFB-4E33-A5D7-61D211AF8B08</gtr:id><gtr:title>Do multiple concurrent infections in African children cause irreversible immunological damage?</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/610ecb6848be4b14451886c6f89d591c"><gtr:id>610ecb6848be4b14451886c6f89d591c</gtr:id><gtr:otherNames>Glennie SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>cQd5HGy9ehF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88C0B74D-D698-415B-B981-1193652976B1</gtr:id><gtr:title>Developmental and tissue-specific regulation of hepatocyte nuclear factor 4-alpha (HNF4-alpha) isoforms in rodents.</gtr:title><gtr:parentPublicationTitle>Gene expression</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785ba76b09bce7acc76e8b3d8a44f123"><gtr:id>785ba76b09bce7acc76e8b3d8a44f123</gtr:id><gtr:otherNames>Dean S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1052-2166</gtr:issn><gtr:outcomeId>c4uRQ7WkFk9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48FDC30F-8A06-4B09-982D-89383EF5037A</gtr:id><gtr:title>Prenatal overexposure to glucocorticoids programs renal 11?-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b7ac8305311090340cdd18aed8fba0"><gtr:id>76b7ac8305311090340cdd18aed8fba0</gtr:id><gtr:otherNames>Tang JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn><gtr:outcomeId>kjSZYfxKFMk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85BD8C29-FAEA-4D6E-9BD7-B782EFB84188</gtr:id><gtr:title>Prenatal glucocorticoid exposure and physiological programming of adult disease</gtr:title><gtr:parentPublicationTitle>Expert Review of Endocrinology &amp; Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6211fd492c2bb3d41fb21174127fced"><gtr:id>e6211fd492c2bb3d41fb21174127fced</gtr:id><gtr:otherNames>Nyirenda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>DE3C4A7C6CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C949955-8210-4E42-8770-7AAC4EFAD2AA</gtr:id><gtr:title>Aldosterone and refractory hypertension.</gtr:title><gtr:parentPublicationTitle>Current opinion in endocrinology, diabetes, and obesity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51058d57f41fe092244e6b11916f761"><gtr:id>d51058d57f41fe092244e6b11916f761</gtr:id><gtr:otherNames>Nyirenda MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1752-296X</gtr:issn><gtr:outcomeId>3E9C212649F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501934</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>